The World Health Organization, in its 2015 research survey, has stated that in the last decade, due to needle stick injury, approximately 2 million healthcare professionals experienced percutaneous exposure to infectious diseases such as Hepatitis B and C virus and HIV. Earlier, prefilled syringes were featured as add-on safety devices, but a technological advancement in the design aspect has introduced an inbuilt safety mechanism. Unilife Corporation was the first manufacturer to market prefilled syringes with integrated safety features. Manufacturers are presently focusing on developing prefilled syringes with auto-retractable needle technology and adopting integrated passive safety mechanisms for prefilled syringes' needle-stick safety.
The market scope for the report on prefilled syringes includes types such as disposable prefilled syringes and reusable prefilled syringes. The materials considered for the report are sub-segmented as plastic prefilled syringes and glass prefilled syringes. The application of prefilled syringes is prevalent in major areas such as diabetes, anaphylaxis, rheumatoid arthritis, and others (biotech drugs and vaccines).
Prefilled syringes market consists of the geographic segments for five regions along with their respective major countries:
North America
U.S.
Canada
Europe
Germany
France
Italy
U.K.
Russia
Rest of Europe
Asia-Pacific
India
China
Japan
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC Countries
South Africa
Rest of Middle East and Africa
The data forecast and market estimation are covered in the geography segment to understand the prevailing market trend in the major countries.
Critical parameters such as product portfolio, geographical presence, and inception help determine the top 3 countries and map the currently existing competition in prefilled syringes market. The company profiles suffice us with the latest technology adopted by the premier players and recent mergers and acquisitions influencing the business milieu of the global prefilled syringes market. The manufacturers seeking a prime position in the global prefilled syringes market are Bayer Healthcare, Gerresheimer AG, Biocon, Becton, Dickinson & Company, Haselmeier AG, Nipro Medical Corporation, Owen Mumford, SCHOTT, Unilife Corporation, and Vetter Pharma International GmbH.
Based on type, the global prefilled syringes market is categorized into
Disposable Prefilled Syringes
Reusable Prefilled Syringes
Prefilled syringes have potential demand among healthcare professionals due to advantages such as convenient drug delivery methods and precise unit dose medication. Furthermore, disposable prefilled syringes have an excellent market on account offor increasing public awareness regarding needle safety and reducing the risk of contamination and infection as the syringes are disposed of immediately after a single use. Furthermore, reusable prefilled syringes are widely employed for drug delivery for chronic diseases. They are available as durable glass and plastic graduated cylinders to adjust the IV bolus and are easy to dismantle, clean, and autoclavable at 2730F. Important players in prefilled syringes market are Bayer Healthcare, Biocon, Becton, Dickinson & Company, Gerresheimer AG, Haselmeier AG, Nipro Medical Corporation, Owen Mumford, SCHOTT, Unilife Corporation, and Vetter Pharma International GmbH.
Based on applications, the global prefilled syringes market is categorized into
Diabetes
Anaphylaxis
Rheumatoid Arthritis
Others (Biotech Drugs and Vaccines)
The conventional syringe vial combination has been replaced by prefilled syringes as they are helpful to healthcare professionals due to the ease of drug injection procedures and time-saving. In addition, the decreasing manufacturing cost of prefilled syringes and their increasing demand from homecare and institutional patients for self-injection will drive the prefilled syringes market. The diabetes segment represents the superior share in prefilled syringes market owing to the rising prevalence of diabetes and increasing demand for prefilled insulin syringes for their excellent results in patients suffering from type 1 diabetes. Furthermore, the anaphylaxis segment employs prefilled syringes in emergencies arising due to anaphylactic shock reactions. In addition, prefilled syringes are used by pharmaceutical companies to store biotech drugs and vaccines that have stability issues while transferring them from vials to syringes.
Based on material, the global prefilled syringes market is categorized into
Plastic Prefilled Syringes
Glass Prefilled Syringes
Prefilled syringe materials have two value additions in healthcare drug delivery: the primary packaging aspects of syringe manufacturing assure that there is no untoward effect on the drug shelf life, strength, and purity; and convenience in administering the appropriate amount of the medication to the patient. Glass syringes have advantages such as optical clarity in which medication volumes are read to the point as the plunger is parallel with the calibration in the syringe, and possess excellent thermal and chemical resistance properties. The drawbacks associated with glass syringes are breakage, potential surface reactivity, leaching, and particulate contamination. Plastic syringes made from cyclic polyolefin resin are gaining tremendous popularity among healthcare professionals. The inherent features of plastic syringes with break resistance, decreased surface reactivity, reduced drug adsorption, and compatible with high and low-pH drug solutions.
The Centers for Disease Control and Prevention has stated in its 2015 report that approximately eighty-six percent of the United States' annual healthcare expenditures are for treating people suffering from chronic ailments. North America is the leader in the global prefilled syringe market as a result of an increasing number of citizens suffering from chronic ailments and enhanced spending in the research and development of prefilled syringes. In Europe, increasing demand for prefilled syringes in homecare settings and the domicile of key players pioneering in manufacturing vaccines and biosimilars will drive its market. The Asia Pacific reflects substantial market opportunity because of the welcoming regulatory environment for prefilled syringes and government spending in developing healthcare infrastructure for middle- and low-income people to avail medication for chronic ailments. In addition, providing healthcare aid by agencies such as the World Health Organization and Red Cross and health awareness campaigns conducted by the premier player will proliferate the prefilled syringes market in the Middle East, Africa, and Latin America.
Frequently asked questions :
The market for Prefilled Syringes Market is expected to reach US$ XX Bn in 2025.
The Prefilled Syringes Market is expected to see significant CAGR growth over the coming years, at XX%.
The report is forecasted from 2017-2025.
The base year of this report is 2016.
Bayer Healthcare, Becton Dickinson and Company, Biocon, Gerresheimer AG, Haselmeier AG, Nipro Medical Corporation are some of the major players in the global market.
